Inventor

Paula Ann Boriack-Sjodin

Inventor
Lexington, MA, US

Overview

27→
Patents
2008–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 27 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes19%
C12NMicroorganisms or enzymes7%
Y02ATechnologies for adaptation to climate change7%
C07KPeptides2%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
10,653,693PRMT5 inhibitors and uses thereof202010,391,089PRMT5 inhibitors and uses therof201910,307,413Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof201910,227,307PRMT1 inhibitors and uses thereof201910,118,918PRMT5 inhibitors and uses thereof201810,039,748PRMT1 inhibitors and uses thereof20189,868,703'PRMT1 inhibitors and uses thereof'20189,776,972'Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof'20179,765,068'PRMT5 inhibitors and uses thereof'20179,745,291'PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof'20179,732,072'PRMT5 inhibitors and uses thereof'20179,732,041'Arginine methyltransferase inhibitors and uses thereof'20179,675,614'PRMT5 inhibitors and uses thereof'20179,604,930'Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof'20179,475,776'PRMT1 inhibitors and uses thereof'20169,447,079'PRMT1 inhibitors and uses thereof'20169,365,519'PRMT5 inhibitors and uses thereof'20169,346,761'Arginine methyltransferase inhibitors and uses thereof'20169,266,836'PRMT5 inhibitors and uses thereof'20169,221,794'PRMT5 inhibitors and uses thereof'20159,023,883'PRMT1 inhibitors and uses thereof'20158,993,555'PRMT5 inhibitors and uses thereof'20158,952,026'PRMT1 inhibitors and uses thereof'20158,940,726'PRMT5 inhibitors and uses thereof'20158,119,114'Polymer conjugates of mutated neublastin'20127,691,865'Pyrazolopyridines and methods of making and using the same'20107,442,370'Polymer conjugates of mutated neublastin'2008

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2008–2012Patents assigned to BIOGEN IDEC INC (3)· patent assignee history
2008–2012Based in Waltham, MA, US· patent location history
2012Patents assigned to BORIACK-SJODIN PAULA ANN (1)· patent assignee history
2012Patents assigned to MILLER STEPHAN S (1)· patent assignee history
2015–2020Patents assigned to EPIZYME INC (24)· patent assignee history
2015–2020Based in Lexington, MA, US· patent location history
2020Patents assigned to GLAXOSMITHKLINE IP DEV LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
EPIZYME INC242015–2020
BIOGEN IDEC INC32008–2012
BORIACK-SJODIN PAULA ANNself12012
GLAXOSMITHKLINE IP DEV LTD12020
MILLER STEPHAN S12012
Locations
LocationPatentsSpan
Lexington, Massachusetts, US242015–2020
Waltham, Massachusetts, US32008–2012